ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 2.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $446,000 | -89.1% | 15,543 | -91.0% | 0.12% | -78.5% |
| Q1 2018 | $4,078,000 | -2.9% | 172,443 | -11.9% | 0.57% | +12.5% |
| Q4 2017 | $4,199,000 | -25.3% | 195,743 | -17.6% | 0.50% | -17.6% |
| Q3 2017 | $5,618,000 | +31.0% | 237,543 | +9.2% | 0.61% | +17.4% |
| Q2 2017 | $4,287,000 | +61.2% | 217,610 | +71.9% | 0.52% | +59.6% |
| Q1 2017 | $2,659,000 | +55.0% | 126,599 | +38.8% | 0.33% | +7.6% |
| Q4 2016 | $1,715,000 | +93.6% | 91,199 | +115.0% | 0.30% | +46.2% |
| Q3 2016 | $886,000 | +68.1% | 42,413 | +105.3% | 0.21% | +57.6% |
| Q2 2016 | $527,000 | +0.8% | 20,663 | +4.6% | 0.13% | -21.9% |
| Q1 2016 | $523,000 | – | 19,763 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |